These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29128384)

  • 21. Effects of measles-containing vaccination in children with severe underlying neurologic disease.
    Dimopoulou D; Koutsaki M; Giorgi M; Spanou M; Dinopoulos A; Papaevangelou V
    Vaccine; 2021 Mar; 39(10):1481-1484. PubMed ID: 33280857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
    Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study.
    Aaby P; Garly ML; Balé C; Martins C; Jensen H; Lisse I; Whittle H
    Pediatr Infect Dis J; 2003 Sep; 22(9):798-805. PubMed ID: 14506371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opportunistic MMR vaccination for unimmunized children at the time of routine teenage booster vaccination in secondary schools: implications for policy.
    Paranthaman K; Bunce A
    Epidemiol Infect; 2012 Sep; 140(9):1612-6. PubMed ID: 22117122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse events following a third dose of measles, mumps, and rubella vaccine in a mumps outbreak.
    Abedi GR; Mutuc JD; Lawler J; Leroy ZC; Hudson JM; Blog DS; Schulte CR; Rausch-Phung E; Ogbuanu IU; Gallagher K; Kutty PK
    Vaccine; 2012 Nov; 30(49):7052-8. PubMed ID: 23041123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measles-rubella mass immunization campaign in Albania, November 2000.
    Bino S; Kakarriqi E; Xibinaku M; Ion-Nedelcu N; Bukli M; Emiroglu N; Uzicanin A
    J Infect Dis; 2003 May; 187 Suppl 1():S223-9. PubMed ID: 12721917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An investigation into a measles outbreak in southeast Iran.
    Izadi S; Zahraie SM; Sartipi M
    Jpn J Infect Dis; 2012; 65(1):45-51. PubMed ID: 22274157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measles and mumps immunization: benefit versus risk factors.
    Krugman S
    Dev Biol Stand; 1979; 43():253-7. PubMed ID: 520672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Measles outbreaks in the Bern canton].
    Maurer AM; Mühlemann K
    Schweiz Med Wochenschr; 1998 Feb; 128(9):317-22. PubMed ID: 9544458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Booster immune response in children 6-7 years of age, randomly assigned to four groups with two MMR vaccines applied by aerosol or by injection.
    Díaz-Ortega JL; Bennett JV; Castañeda-Desales D; Quintanilla DM; Martínez D; de Castro JF
    Vaccine; 2014 Jun; 32(29):3680-6. PubMed ID: 24837512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measles and Measles Vaccination: A Review.
    Bester JC
    JAMA Pediatr; 2016 Dec; 170(12):1209-1215. PubMed ID: 27695849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measles immunization of 2-year-olds in a rural southern state.
    Feldman S; Andrew M; Gilbert J; Bracken B; Thompson FE
    JAMA; 1994 May; 271(18):1417-20. PubMed ID: 8176803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical measles in adolescent siblings 16 years after killed measles virus vaccine.
    Fulginiti VA; Helfer RE
    JAMA; 1980 Aug 22-29; 244(8):804-6. PubMed ID: 7392190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measles in secondary school children: implications for vaccination policy.
    Calvert N; Cutts F; Miller E; Brown D; Munro J
    Commun Dis Rep CDR Rev; 1994 May; 4(6):R70-3. PubMed ID: 7519515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-specific effects of childhood vaccinations - A case control study nested into a Health and Demographic Surveillance System in rural Burkina Faso.
    Pfeiffer G; Fisker AB; Nebié E; Hengelbrock J; Sié A; Becher H; Müller O
    Vaccine; 2017 Dec; 35(51):7114-7120. PubMed ID: 29153586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A general measles vaccination campaign in urban Guinea-Bissau: Comparing child mortality among participants and non-participants.
    Byberg S; Thysen SM; Rodrigues A; Martins C; Cabral C; Careme M; Aaby P; Benn CS; Fisker AB
    Vaccine; 2017 Jan; 35(1):33-39. PubMed ID: 27890397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measles outbreak in 31 schools: risk factors for vaccine failure and evaluation of a selective revaccination strategy.
    Yuan L
    CMAJ; 1994 Apr; 150(7):1093-8. PubMed ID: 8137189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measles in Europe: an epidemiological assessment.
    Muscat M; Bang H; Wohlfahrt J; Glismann S; Mølbak K;
    Lancet; 2009 Jan; 373(9661):383-9. PubMed ID: 19131097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Post-vaccinal adverse effects monitoring during national campaign of vaccination against measles in Côte d'Ivoire].
    Die-Kacou H; Yavo JC; Kakou KA; Kamagaté M; Balayssac E; Daubrey PT; Gboignon VM
    Bull Soc Pathol Exot; 2009 Feb; 102(1):21-5. PubMed ID: 19343916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.
    Nakayama T; Onoda K
    Vaccine; 2007 Jan; 25(3):570-6. PubMed ID: 16945455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.